Literature DB >> 34017929

Evaluation of Quantitative Structure Property Relationship Algorithms for Predicting Plasma Protein Binding in Humans.

Yejin Esther Yun1, Rogelio Tornero-Velez2, S Thomas Purucker2, Daniel T Chang2, Andrea N Edginton1.   

Abstract

The extent of plasma protein binding is an important compound-specific property that influences a compound's pharmacokinetic behavior and is a critical input parameter for predicting exposure in physiologically based pharmacokinetic (PBPK) modeling. When experimentally determined fraction unbound in plasma (fup) data are not available, quantitative structure-property relationship (QSPR) models can be used for prediction. Because available QSPR models were developed based on training sets containing pharmaceutical-like compounds, we compared their prediction accuracy for environmentally relevant and pharmaceutical compounds. Fup values were calculated using Ingle et al., Watanabe et al. and ADMET Predictor (Simulation Plus). The test set included 818 pharmaceutical and environmentally relevant compounds with fup values ranging from 0.01 to 1. Overall, the three QSPR models resulted in over-prediction of fup for highly binding compounds and under-prediction for low or moderately binding compounds. For highly binding compounds (0.01≤ fup ≤ 0.25), Watanabe et al. performed better with a lower mean absolute error (MAE) of 6.7% and a lower mean absolute relative prediction error (RPE) of 171.7 % than other methods. For low to moderately binding compounds, both Ingle et al. and ADMET Predictor performed better than Watanabe et al. with superior MAE and RPE values. The positive polar surface area, the number of basic functional groups and lipophilicity were the most important chemical descriptors for predicting fup. This study demonstrated that the prediction of fup was the most uncertain for highly binding compounds. This suggested that QSPR-predicted fup values should be used with caution in PBPK modeling.

Entities:  

Keywords:  Plasma protein binding; environmentally relevant chemicals; human health risk assessment; quantitative structure-property relationship (QSPR) models

Year:  2021        PMID: 34017929      PMCID: PMC8128700          DOI: 10.1016/j.comtox.2020.100142

Source DB:  PubMed          Journal:  Comput Toxicol        ISSN: 2468-1113


  44 in total

1.  Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.

Authors:  Barbara A Wetmore; John F Wambaugh; Stephen S Ferguson; Mark A Sochaski; Daniel M Rotroff; Kimberly Freeman; Harvey J Clewell; David J Dix; Melvin E Andersen; Keith A Houck; Brittany Allen; Richard S Judson; Reetu Singh; Robert J Kavlock; Ann M Richard; Russell S Thomas
Journal:  Toxicol Sci       Date:  2011-09-26       Impact factor: 4.849

Review 2.  Drug-protein binding sites. New trends in analytical and experimental methodology.

Authors:  J Oravcová; B Böhs; W Lindner
Journal:  J Chromatogr B Biomed Appl       Date:  1996-02-23

3.  Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.

Authors:  Guo-Fu Li; Guo Yu; Yanfei Li; Yi Zheng; Qing-Shan Zheng; Hartmut Derendorf
Journal:  J Pharm Sci       Date:  2018-03-06       Impact factor: 3.534

4.  Binding of digitoxin, digoxin and gitoxin to human serum albumin.

Authors:  J P Tillement; R Zini; M Lecomte; P d'Athis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

5.  Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios.

Authors:  J Cory Kalvass; Tristan S Maurer; Gary M Pollack
Journal:  Drug Metab Dispos       Date:  2007-01-19       Impact factor: 3.922

6.  Predicting Fraction Unbound in Human Plasma from Chemical Structure: Improved Accuracy in the Low Value Ranges.

Authors:  Reiko Watanabe; Tsuyoshi Esaki; Hitoshi Kawashima; Yayoi Natsume-Kitatani; Chioko Nagao; Rikiya Ohashi; Kenji Mizuguchi
Journal:  Mol Pharm       Date:  2018-09-27       Impact factor: 4.939

7.  The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding.

Authors:  Xiang-Wei Zhu; Alexander Sedykh; Hao Zhu; Shu-Shen Liu; Alexander Tropsha
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

8.  KEGG: new perspectives on genomes, pathways, diseases and drugs.

Authors:  Minoru Kanehisa; Miho Furumichi; Mao Tanabe; Yoko Sato; Kanae Morishima
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

9.  New approach for understanding genome variations in KEGG.

Authors:  Minoru Kanehisa; Yoko Sato; Miho Furumichi; Kanae Morishima; Mao Tanabe
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing.

Authors:  Barbara A Wetmore; John F Wambaugh; Brittany Allen; Stephen S Ferguson; Mark A Sochaski; R Woodrow Setzer; Keith A Houck; Cory L Strope; Katherine Cantwell; Richard S Judson; Edward LeCluyse; Harvey J Clewell; Russell S Thomas; Melvin E Andersen
Journal:  Toxicol Sci       Date:  2015-08-06       Impact factor: 4.849

View more
  3 in total

1.  Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.

Authors:  Abdulkarim Najjar; Ans Punt; John Wambaugh; Alicia Paini; Corie Ellison; Styliani Fragki; Enrica Bianchi; Fagen Zhang; Joost Westerhout; Dennis Mueller; Hequn Li; Quan Shi; Timothy W Gant; Phil Botham; Rémi Bars; Aldert Piersma; Ben van Ravenzwaay; Nynke I Kramer
Journal:  Arch Toxicol       Date:  2022-09-05       Impact factor: 6.168

Review 2.  IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

Authors:  Xiaoqing Chang; Yu-Mei Tan; David G Allen; Shannon Bell; Paul C Brown; Lauren Browning; Patricia Ceger; Jeffery Gearhart; Pertti J Hakkinen; Shruti V Kabadi; Nicole C Kleinstreuer; Annie Lumen; Joanna Matheson; Alicia Paini; Heather A Pangburn; Elijah J Petersen; Emily N Reinke; Alexandre J S Ribeiro; Nisha Sipes; Lisa M Sweeney; John F Wambaugh; Ronald Wange; Barbara A Wetmore; Moiz Mumtaz
Journal:  Toxics       Date:  2022-05-01

3.  Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.

Authors:  Daniel E Dawson; Brandall L Ingle; Katherine A Phillips; John W Nichols; John F Wambaugh; Rogelio Tornero-Velez
Journal:  Environ Sci Technol       Date:  2021-04-15       Impact factor: 9.028

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.